Search for Tradename: benicar
Summary for Tradename: benicar
|
|
Latest news for BENICARCombination Drug Approved for High Blood Pressure28 July 2010, 3:22 am Daiichi Sankyo says FDA clears blood pressure drug26 July 2010, 9:06 am Zacks Analyst Blog Highlights: Microsoft, PepsiCo, Forest Laboratories, Cypress Biosciences and Morgan Stanley21 July 2010, 8:04 am Forest Labs Tops Zacks Consensus20 July 2010, 1:22 pm Forest Labs Q1 Profit Falls On Charges; Lifts Full-year Earnings View - Update20 July 2010, 10:22 am Press Release20 July 2010, 9:34 am Forest Laboratories, Inc. Reports First Quarter FY 2011 EPS of $0.39, Including $0.39 Per Share Charge Related to ...20 July 2010, 8:00 am FDA will review angiotensin-receptor blockers (ARBs) for cancer risk16 July 2010, 3:18 pm FDA takes a closer look at possible cancer risks of widely used blood pressure medicines15 July 2010, 5:09 pm Courtesy of Yahoo News |
Glossary
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | Aug 4, 2010 | |||||
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | Feb 4, 2013 | |||||
| Daiichi Sankyo | BENICAR | olmesartan medoxomil | 021286 | Apr 25, 2002 | RX | No | 5,616,599*PED | Y | Oct 25, 2016 |
This preview shows a limited data set. Complete access is available with a Subscription
Paragraph IV activity for: BENICAR
| Drugname | Dosage | Strength | RLD | Submissiondate |
| olmesartan medoxomil and hydrochlorothiazide | Tablets | 20 mg/12.5 mg | Benicar HCT | 5/11/2007 |
| olmesartan medoxomil and hydrochlorothiazide | Tablets | 40 mg/12.5 mg and 40 mg/25 mL | Benicar HCT | 2/15/2007 |
| olmesartan medoxomil | Tablets | 5 mg, 20 mg and 40 mg | Benicar | 4/25/2006 |
<- Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.
Follow DrugPatentWatch on Twitter![[del.icio.us]](/inc/bookmarkify/delicious.png)
![[Digg]](/inc/bookmarkify/digg.png)
![[Reddit]](/inc/bookmarkify/reddit.png)
![[Facebook]](/inc/bookmarkify/facebook.png)
![[LinkedIn]](/inc/bookmarkify/linkedin.png)
![[StumbleUpon]](/inc/bookmarkify/stumbleupon.png)
![[Technorati]](/inc/bookmarkify/technorati.png)
![[Twitter]](/inc/bookmarkify/twitter.png)
![[Email]](/inc/bookmarkify/email.png)